Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

X Tong

Showing results (231-240 of 325) with videos related to

Pageof 33
Sort By:
Hybridoma|April 22, 1999
Comparison of long-term survival of cytomegalovirus promotre versus Rous Sarcoma virus promoter-driven thymidine kinase gene therapy in nude mice bearing human ovarian cancerX Tong, D G Engehausen, C T Freund, et al.
Zoonoses and Public Health|December 24, 2016
Experts' Perceptions on China's Capacity to Manage Emerging and Re-emerging Zoonotic Diseases in an Era of Climate ChangeA Hansen, J Xiang, Q Liu, et al.
American Journal of Medical Genetics|April 17, 2001
A follow-up linkage study supports evidence for a bipolar affective disorder locus on chromosome 21q22J Liu, S H Juo, J D Terwilliger, et al.
Public Health|May 10, 2016
Risk factors for hospitalisation and associated costs among patients with hepatitis A associated with imported pomegranate arils, United States, 2013E E Epson, A Cronquist, K Lamba, et al.
Blood|June 5, 2001
Biology and outcome of childhood acute megakaryoblastic leukemia: a single institution's experienceU H Athale, B I Razzouk, S C Raimondi, et al.
Leukemia|October 6, 2000
Treatment of childhood acute myelogenous leukemia with an intensive regimen (AML-87) that individualizes etoposide and cytarabine dosages: short- and long-term effectsM K Arnaout, K M Radomski, D K Srivastava, et al.
Genes and Immunity|April 18, 2008
Associations between the human MHC and sustained virologic response in the treatment of chronic hepatitis C virus infectionS L Rhodes, H Erlich, K A Im, et al.
Biorxiv : the Preprint Server for Biology|August 4, 2022
Waning and boosting of functional humoral immunity to SARS-CoV-2X Tong, R P McNamara, M J Avendaño, et al.
Parasite Immunology|March 27, 2015
The potential long-term effect of previous schistosome infection reduces the risk of metabolic syndrome among Chinese menS-W Shen, Y Lu, F Li, et al.
Antimicrobial Agents and Chemotherapy|March 24, 2010
Preclinical characterization of the antiviral activity of SCH 900518 (narlaprevir), a novel mechanism-based inhibitor of hepatitis C virus NS3 proteaseX Tong, A Arasappan, F Bennett, et al.
Pageof 33

Showing results (231-240 of 325) with videos related to

Sort By:
Pageof 33
Hybridoma|April 22, 1999
Comparison of long-term survival of cytomegalovirus promotre versus Rous Sarcoma virus promoter-driven thymidine kinase gene therapy in nude mice bearing human ovarian cancerX Tong, D G Engehausen, C T Freund, et al.
Zoonoses and Public Health|December 24, 2016
Experts' Perceptions on China's Capacity to Manage Emerging and Re-emerging Zoonotic Diseases in an Era of Climate ChangeA Hansen, J Xiang, Q Liu, et al.
American Journal of Medical Genetics|April 17, 2001
A follow-up linkage study supports evidence for a bipolar affective disorder locus on chromosome 21q22J Liu, S H Juo, J D Terwilliger, et al.
Public Health|May 10, 2016
Risk factors for hospitalisation and associated costs among patients with hepatitis A associated with imported pomegranate arils, United States, 2013E E Epson, A Cronquist, K Lamba, et al.
Blood|June 5, 2001
Biology and outcome of childhood acute megakaryoblastic leukemia: a single institution's experienceU H Athale, B I Razzouk, S C Raimondi, et al.
Leukemia|October 6, 2000
Treatment of childhood acute myelogenous leukemia with an intensive regimen (AML-87) that individualizes etoposide and cytarabine dosages: short- and long-term effectsM K Arnaout, K M Radomski, D K Srivastava, et al.
Genes and Immunity|April 18, 2008
Associations between the human MHC and sustained virologic response in the treatment of chronic hepatitis C virus infectionS L Rhodes, H Erlich, K A Im, et al.
Biorxiv : the Preprint Server for Biology|August 4, 2022
Waning and boosting of functional humoral immunity to SARS-CoV-2X Tong, R P McNamara, M J Avendaño, et al.
Parasite Immunology|March 27, 2015
The potential long-term effect of previous schistosome infection reduces the risk of metabolic syndrome among Chinese menS-W Shen, Y Lu, F Li, et al.
Antimicrobial Agents and Chemotherapy|March 24, 2010
Preclinical characterization of the antiviral activity of SCH 900518 (narlaprevir), a novel mechanism-based inhibitor of hepatitis C virus NS3 proteaseX Tong, A Arasappan, F Bennett, et al.
Pageof 33